Pradaxa®

Prevention of strokes and blood clots in patients with abnormal heart rhythm (atrial fibrillation).
Primary prevention of venous thrombo-embolic events (VTE) in adults after elective total hip or knee replacement surgery.
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and secondary prevention of recurrent DVT and PE in adults.

 

Indications Stroke prevention in atrial fibrillation
Primary prevention of venous thromboembolic events after orthopaedic surgery
Treatment and secondary prevention of venous thromboembolic events
Brand Names Pradaxa®
Pradaxar®
Prazaxa®
Active ingredients dabigatran etexilate
Packshot Pradaxa<sup>®</sup>